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Diabetes mellitus (DM) is a major global health concern 
worldwide. The World Health Organization (WHO) 
estimated that globally high blood glucose is the third 
highest risk factor for premature mortality, after high 
blood pressure and tobacco use. In Malaysia, the  
National Health and Morbidity Survey (NHMS) 2015 
reported that the prevalence of diabetes mellitus 
increases from 15.2% in 2011 to 17.5% in 2015 in which  
undiagnosed group predominated.1 The National 
Diabetes Registry 2012 showed that the majority of 
patients were not well controlled. Only 23.8% of type 2 
diabetes mellitus (T2DM) patients achieved good 
glycemic control; and majority of them developed 
complications such as obesity and dyslipidemia.2 
 
With high prevalence of diabetes mellitus along with              
its chronic nature and known complications, patient         
opted for traditional and complementary medicine 
(T&CM) either as an alternative or concomitant with 
conventional therapy.3-6 T&CM is a form of health-
related practice which includes traditional practices, 
homeopathy, and complementary therapies and 
excluding medical and dental practices with the aim to 
prevent, treat or manage ailment or illness; or preserve 
the mental and physical well- being of an individual.7 
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INTRODUCTION: Diabetes mellitus is a major global health concern worldwide. The fact that it is a lifelong chronic illness 
contributes to the increasing tendency of seeking traditional and complementary medicine (T&CM), yet study regarding this 
remains limited. This study aimed to measure the prevalence of T&CM use among diabetic patients and its association with 
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medical ward and those attending diabetic clinic were interviewed regarding the use of T&CM; and their blood investigation 
results were collected from patients’ medical records. A data collection form was used as study instrument.  Descriptive statistic 
was used to measure the prevalence while chi-square test and independent t-test were used to find associations between T&CM 
use and study background and diabetic control. RESULTS: Low prevalence of T&CM use (16.9%) was found, predominated 
by retiree group (p<0.05). Majority of patients used T&CM as additional treatment for diabetes (60.9%) and the usage was 
influenced by friends, family members and advertisement. There was a significant difference in Glycosylated haemoglobin A1c 
(HbA1c) and Estimated Glomerular Filtration Rate (eGFR) levels between inpatient and outpatient T&CM users (p<0.05). 
CONCLUSION: 1 in every 6 diabetic patients in HTAA, Kuantan were using T&CM along with conventional diabetic 
medications in which retirees are predominated. No associations were found between T&CM uses and diabetic control. 
Outpatient T&CM users had lower  HbA1c level with higher eGFR compared to inpatient users.  
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Globally the trend of T&CM uses showed an increment 
widely. Earlier study in Taiwan showed that 61%  of 
diabetic patients were using T&CM.5 Similar prevalence 
of 62.5% was seen in  in Sepang, Selangor in Malaysia.8 
It was also consistent with other previous studies done 
in Malaysia.9-10 It was suggested that age, gender, 
ethnicity and economic status influence the usage of 
T&CM along with the duration of diabetes and 
presence of co- morbidities.11-12 
 
Despite the rise in interest of T&CM usage among 
diabetic patients, earlier studies were focusing more on 
the outpatient instead of comparing both inpatient and 
outpatient T&CM users. Besides the knowledge about 
possible positive and negative effects of T&CM on 
diabetic controls and its interaction with the current 
treatments remains limited.6,13-14 Hence, our present 
study aimed to explore the prevalence and factors  
influencing the usage of T&CM among diabetic 
inpatients and outpatients, and to find the association 
between T&CM use and diabetic control.  
 
MATERIAL AND METHODS 
 
A cross-sectional study was carried out among diabetic 
inpatients from medical ward and outpatients  attending 
for regular follow up at the diabetic clinic in Hospital 
Tengku Ampuan Afzan (HTAA), Kuantan, Pahang 
from 16th July to 24th August 2018. 
 
 The study involved type 2 diabetic patients aged more 
than 18 years with minimum of 3 months follow up at 
healthcare center; or after being diagnosed. The 
exclusion criteria included patients with psychiatric 
disorders and pregnant women. The sample size was 
calculated using Epitools epidemiological calculator (2 
tailed) based on the prevalence in previous studies.10,15 
The estimated sample size was 120 with confidence 
interval (CI) of 95%.Considering the non-response           
rate of 12%, the total number of respondents was 136        
with 68 respondents in each diabetic inpatients and 
outpatients. Convenience sampling was used due to the  
unavailability of diabetes registry. 
 
A face-to-face interview was conducted using a bilingual 
version of data collection form adapted from previous 
study and all the required blood results were taken from 
the latest hospital medical records.10 The data collection 
form consisted of 4 sections including: 
 
A. Demographics and socio-economic information 
B. Different treatment combinations utilized by 
patients 
C. Blood investigations result 
D. Specific reasons to start and use T&CM 
 
Descriptive and analytical statistics were carried out 
using SPSS version 25. The findings were recorded as 
frequencies, percentages, means and standard deviation 
(SD). Bi-variable analysis on categorical data was done 
using Chi -Square test while independent samples t-test 
was used for normally distributed numerical data. A p-
value of < 0.05 was considered statistically significant. 
 
All related approval were obtained for this study, i.e. 
hospital director, Medical Research Ethics Committee 
(MREC) (NMRR-18-1378-42080) and International 





Demographic and socio- economic profiles  
 
A total of 136 patients (68 inpatients and 68 outpatients) 
were recruited in this study. The mean age was 58.15 
years and the majority of the respondents were female 
(54.4%). The demographic and socio-economic profiles 
of the interviewed patients were presented in Table I.   
 
T&CM use among diabetic patients and its 
association with study background characteristics 
 
Out of 136 respondents, 23  (16.9%) were found to   be 
T&CM users; with 11 from inpatient and 12             
from outpatient respondents (16.2 % and 17.6% 
respectively). A significant number of T&CM users 
(43.5%) were from retiree age group (p < 0.05). 
 
Reasons to start and use of T&CM 
 
More than half of the T&CM users (60.9%) started to 
use T&CM for the purpose of additional treatment for 
diabetes, followed by 21.8% who believed in the 
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established efficacy of T&CM. While a minority of them 
had family history of T&CM use (13%) and only 4.3% 
used it in view of fewer adverse effects of T&CM. 
Friends were the main influencer in T&CM use (34.9%), 
*mean (SD) 
followed by family members and advertisement with a 
similar proportion (30.4%), and health professionals 
(4.3%). 
 
Association between T&CM use and Diabetic 
Control  
 
Association between T&CM use and diabetic control 
was presented in Table II. Majority of respondents had 
poor HbA1c level (82.6% among T&CM users and 
86.7% among non T&CM user) with at least moderate 
eGFR values of more than 30 mL/min/1.73 m2 (82.6% 
among T&CM users and 87.6% among non T&CM 
user). T&CM use was not significantly associated with 
diabetic control with p-value of 0.604 for HbA1c and 
0.519 for eGFR. 
Study background characteristics n= 136 % 
Gender Male 62 45.6 
Female 74 54.4 
Age 58.15 (1.043)* 
Education level No formal schooling 10 7.4 
Primary school 39 28.7 
Secondary school 70 51.5 
Tertiary school 17 12.5 
Race Malay 106 77.9 
Chinese 14 10.3 
Indian 16 11.8 
Marital status Married 103 75.7 
Unmarried 7 5.1 
Divorced 4 2.9 
Widowed 22 16.2 
Work status Working 45 33.1 
Housewife 36 26.5 
Retiree 28 20.6 
Unemployed  27 19.9 
Monthly income 
(RM) 
Low income 98 72.1 
Middle income 17 12.5 




OAD 36 26.5 




OAD+insulin 53 39 
T&CM+insulin 9 6.6 
insulin 24 17.6 













Good 4 15 0.604 
Poor 19 98 
  
   eGFR 
Good 19 99 0.519 
Poor 4 14 
Table II: Association between T&CM Use and Diabetic Control 
Association between diabetic inpatients and 
outpatients T&CM users with diabetic control  
 
Table III demonstrated association between diabetic 
inpatients and outpatients T&CM users with diabetic 
control. A significant association found between 
diabetic inpatients and outpatients T&CM users with 
HbA1c in which all the outpatient T&CM users had 
poor HbA1c level while only 63.6% of inpatient group 
had poor HbA1c level. Also, a significant difference was 
illustrated in terms of eGFR level in which all the 
outpatient T&CM users showed good eGFR level while 
only 63.6% of inpatient group had good eGFR level. 
Hence, the overall results showed that the outpatient 
users had poorer HbA1c level with better eGFR level 
compared to inpatient users. 
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n= 12 (%) 
  
HbA1c 
Good 4 (36.4%) 0 (0%) 0.022 
Poor 7 (63.6%) 12 (100%) 
  
eGFR 
Good 7 (63.6%) 12 (100%) 0.022 
Poor 4 (36.4%) 0 (0%) 
Table III: Association between Diabetic Inpatient and 
Outpatient T&CM Users with Diabetic Control 
DISCUSSION 
 
Our study showed low prevalence of T&CM users 
(16.9%) among diabetic patients which was in contrast 
with the  studies done in globally and locally.9,16-17 This 
big gap of difference may be related to the possibility of 
underreported cases among the users. The percentage of 
T&CM users for diabetic inpatients and outpatients 
were comparatively similar, which were 16.2% and 
17.6%, respectively. 
 
More than half of the respondents (60.9%)  started to 
use T&CM as an additional treatment for diabetes which 
is similar to earlier study.8,18 The positive views on 
T&CM usage were  its organic nature, preferences to be 
treated holistically and increased availability of T&CM 
were among the pulling factors toward it.8 
 
The usage of T&CM was influenced by friends (34.9%), 
followed by family and advertisements (30.4%) and 
lastly by health professionals (4.3%) which was similarly 
reported previously.10 
 
Retiree was significantly found to be the predominant 
group of T&CM users. This finding correlated with 
mean age of our respondents in which 58.15 years old 
reflecting the beginning of retiring age.19 Being older and 
retired provided them ample time to explore the T&CM, 
thus influencing the purchasing behavior.20 However, 
this finding differed from the NHMS 2015 in which 
employed people tend to use T&CM more compared to 
the retirees.3 This discrepancy could be explained by the 
different study population and methodology of research 
used. 
 
Older, married, female patients with higher levels of 
education and household income were more likely to be 
the T&CM users in some studies.11-12,18,21 However, the 
present study found no significant relationship between 
T&CM use with gender, mean age, ethnic group, 
education level, marital status and household income.   
 
The plausible explanation for this could be that our 
study population was diabetic patients, who might be 
more likely resorting for T&CM therapies regardless of 
age, gender or socio-demographic status.8 It was 
reported in the United States that diabetic patients were 
1.6 times more likely to use T&CM than non-diabetics.22 
Besides, the result might be influenced by our smaller 
sample size, along with the smaller percentage of T&CM 
users (16.9%) in this present study. 
 
No significant association was found between T&CM 
use with level of HbA1c and eGFR. Similar findings 
were reported in the local and global data.8,10,23 
However, the result was inconclusive as other co-
founding factors should be taken into consideration as 
the compliance, treatment modalities and pharmacology 
effect of oral anti-diabetic drugs (OAD) and insulin 
could affect the HbA1c as well as other parameters that 
also can affect the eGFR.10,24-25 
 
Among T&CM users, 83% of them had poor HbA1c 
level with good eGFR. This was possibly due to 
hyperglycemic effect in early stage diabetes, causing 
glomerular hyperfiltration.26 However, this finding could 
not be generalized as the duration of illness was not 
specified in this study. Looking at each parameter, when 
comparing between inpatient and outpatient T&CM 
users, a significant difference was illustrated in terms of 
HbA1c and eGFR. The outpatient group was 
significantly having poorer HbA1c level compared to 
inpatients. In contrary, inpatients T&CM users recorded 
a poorer eGFR than outpatients, reflecting more severe 
stage of chronic kidney disease. It was reported 
previously that the risk of developing kidney failure 
increased with consumption of herbal supplements.13 
The kidney function itself could be exacerbated with the 
chronicity of the disease itself along with other 
comorbid conditions in hospitalized patients. 
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 CONCLUSION AND  RECOMMENDATION 
 
This study revealed low prevalence of T&CM use 
among diabetic patients (16.9%) with retiree group of 
respondents predominated. Majority of them used 
T&CM as additional treatment for diabetes; with 
friends, family members and advertisement as the main 
influential factors in starting and using T&CM. T&CM 
use was not significantly associated with diabetic 
control. However, a noticeable difference in HbA1c & 
eGFR level was reported between inpatient and 
outpatient T&CM users. 
 
Although  low prevalence of T&CM users was 
demonstrated, this issue could not be taken lightly. The 
findings in this study could be used to improve 
healthcare professional awareness in considering other 
potential risks and benefits of T&CM therapies; hence 
providing more information to the  patients as well as to 
their family members regarding T&CM. Also, in 
managing this issue, a more focused approach should be 
targeted to the identified group. Lastly, future research 
should be conducted as randomized clinical trial to 
provide strong evidence-based findings in terms of 
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